https://www.selleckchem.com/pr....oducts/trastuzumab-e
To determine whether erenumab is effective and safe in refractory chronic migraine with medication overuse headache. In this prospective, multicentric, real-life study, chronic migraine with medication overuse headache patients who received erenumab were recruited. Study inclusion was limited to patients who previously failed onabotulinumtoxinA in addition to at least three other pharmacological commonly used migraine preventive medication classes. Of 396 patients who received erenumab, 38% (n = 149) met inclusion c
Like
Comment
Share
